Jump To Top

groundrushairsports

HIMSS21 tech news: New conversational AI, IT-enabled home diagnostic testing

Orbita, a vendor of secure voice and chatbot virtual-assistant solutions for healthcare, has launched an upgrade to its conversational AI platform for healthcare, along with deployments with four healthcare organizations using Orbita to power automated patient engagement and support.

Orbita’s new Solution Center is an integrated system for quickly deploying secure, scalable, omnichannel voice and chatbot virtual assistants for healthcare’s digital front door. Using a modular, plug-and-play architecture, the Solution Center includes prebuilt interoperable services to streamline deployment of feature-rich healthcare virtual assistants.

The technology is designed to help healthcare organizations improve patient engagement and close gaps in care, while reducing operational costs and staff burden. The Solution Center includes out-of-the-box solutions for voice and chatbot applications that can be quickly integrated to support a variety of intelligent patient engagement operations.

“We saw a real need in the industry to go beyond the limitations of: 1) generic chatbot platforms that lack healthcare capabilities and 2) point solutions that lack scale and flexibility,” said Patty Riskind, CEO at Orbita. “Solution Center is the culmination of many years of research and development, and delivers on the promise of out-of-the-box solutions combined with enterprise-grade flexibility and robustness that the healthcare industry demands.”

Clients include Medstar Health, Novartis, Mass General Brigham, KKI, Mayo Clinic, Amwell, Janssen, Roche, Yale New Haven Hospital, Bristol Myers Squibb and Cancer Treatment Centers of America.

Orbita is in HIMSS21 booth 1630-01.

IT-enabled home diagnostic testing

Affinity Empowering, a vendor of occupational, behavioral and direct-to-consumer health services, has unveiled two new brands: Affinity eHome, which will expand the company’s at-home and near-home diagnostic-testing capabilities, and Affinity eCare, which will personalize and optimize the healthcare experience by helping individuals identify the appropriate provider for their needs.

Affinity eHome is designed to provide a streamlined experience for the consumer in need of diagnostic testing services. The brand will be run through Affinity’s HIPAA-compliant technology platform, Assure, which allows for appointment scheduling, secure messaging, results reporting, consent management, video/telehealth appointments and more.

Affinity aims for eHome to provide more than 300 different diagnostic-testing options to consumers, with the ability to either directly deliver those tests to a user’s home or to provide the user with information about local medical providers with the ability to perform the testing service needed.

Affinity eCare is designed to synthesize patient health information into meaningful outcomes. This information, including reports from trusted providers and diagnostic results from Affinity eHome testing, can be used to identify the appropriate specialists for a patient’s health needs.

eCare is then incorporated into the patient’s treatment plan, as providers will input comprehensive wellness assessments that can be monitored over time to ensure progress. To best serve patients, eCare team members are also able, with consent, to communicate up-to-date treatment information between different healthcare providers, ensuring that each is as informed as possible.

“Affinity eHome and eCare were created with the idea that every person deserves the right to better understand their own health,” said Michael Tkach, chief behavioral health officer and COO at Affinity Empowering. “eHome will empower individuals to navigate their personal health-and-wellness journey with confidence and convenience, and eCare will empower them to take that next step towards finding the best possible care.”

Twitter: @SiwickiHealthIT
Email the writer: [email protected]
Healthcare IT News is a HIMSS Media publication.

Source: Read Full Article

  • Posted on August 12, 2021